What Parents Need to Know About Newborn Jaundice: Screening, Treatment, and When Untreated Bilirubin Becomes a Birth Injury Concern

Neonatal jaundice is one of the most common conditions parents encounter in the first days after birth. The yellowing of a baby’s skin and eyes can be alarming, but understanding what jaundice is, how it is treated, and when it requires medical attention can help parents feel more confident during this critical time. Neonatal jaundice, clinically known as neonatal hyperbilirubinemia, affects more than half of all term infants. While most cases are benign and resolve without intervention, untreated severe hyperbilirubinemia can lead to serious neurological complications, including permanent brain damage. This guide provides parents with essential information about jaundice screening, treatment, risk factors, and when to seek help.

What Is Neonatal Jaundice?

Neonatal jaundice occurs when elevated levels of bilirubin, a yellow pigment produced during the normal breakdown of red blood cells, accumulate in a newborn’s blood. In adults and older children, the liver efficiently processes and eliminates bilirubin. However, newborns have immature liver function, which can lead to temporary difficulty clearing bilirubin from the bloodstream. This accumulation causes the characteristic yellowing of the skin and the whites of the eyes.

Jaundice is not a disease itself but rather a symptom of elevated bilirubin levels. In most cases, the condition is physiologic, meaning it is a normal part of newborn development and resolves on its own within one to two weeks. However, some infants develop pathologic jaundice, which appears earlier, rises more rapidly, or persists longer than typical cases. Pathologic jaundice may indicate an underlying condition such as blood type incompatibility, infection, or a metabolic disorder.

The concern with severe hyperbilirubinemia is the risk of acute bilirubin encephalopathy, a condition where high bilirubin levels affect brain function. If untreated, this can progress to kernicterus, a rare but permanent form of brain damage that can cause cerebral palsy, hearing loss, vision problems, and developmental delays. Early detection and appropriate treatment are critical to preventing these serious outcomes.

Common Symptoms and Red Flags

Parents should know what to look for when monitoring their newborn for jaundice. The most obvious sign is yellowing of the skin and eyes, which typically starts on the face and progresses downward to the chest, abdomen, and legs as bilirubin levels rise. The yellowing may be more difficult to see in babies with darker skin tones, making medical screening especially important.

Red flags:

• Jaundice that appears within the first 24 hours of life.

• Excessive sleepiness or difficulty waking for feedings.

• Poor feeding or refusal to feed.

• Arching backward or high-pitched crying.

• Yellowing that extends to the palms or soles (often indicating higher bilirubin levels).

Parents should also be aware that jaundice can sometimes be accompanied by pale stools or dark urine. While newborn stool color varies, very pale or chalky stools combined with jaundice may indicate a problem with bile flow and should be evaluated by a healthcare provider.

How Jaundice Is Screened and Diagnosed

New York hospitals follow standard screening protocols to identify jaundice early. All newborns should receive a transcutaneous bilirubin test at approximately 24 hours of age. This non-invasive screening tool uses a handheld device placed against the baby’s skin to estimate bilirubin levels without requiring a blood draw.

While transcutaneous bilirubin screening is convenient and painless, it is not the definitive diagnostic test. If the screening result is elevated or if a baby shows visible signs of jaundice, healthcare providers will order a total serum bilirubin test, which requires a small blood sample and provides the most accurate measurement. This blood test is the gold standard for diagnosing hyperbilirubinemia and determining whether treatment is needed.

The timing of screening is important. Jaundice that appears before 24 hours of age requires immediate testing because it may indicate a pathologic condition rather than the common physiologic jaundice. Healthcare providers use risk nomograms, which are charts that plot bilirubin levels against the baby’s age in hours, to determine the severity of hyperbilirubinemia and guide treatment decisions.

Before discharge from the hospital, healthcare providers should assess each baby’s risk for developing severe hyperbilirubinemia. This assessment considers factors such as the baby’s gestational age, feeding method, weight loss, and family history. Based on this risk assessment, providers develop a follow-up plan that may include additional bilirubin testing within 24 to 48 hours after discharge.

Standard Treatments Including Phototherapy and Exchange Transfusion

The primary treatment for neonatal jaundice is phototherapy, commonly known as light therapy. During phototherapy, the baby is placed under special blue lights that help break down bilirubin in the skin so it can be eliminated more easily. The treatment is painless and highly effective for most cases of hyperbilirubinemia.

Phototherapy is used when bilirubin levels reach specific thresholds. The American Academy of Pediatrics issued updated clinical guidelines in 2022 that revised treatment thresholds and introduced more individualized risk assessment tools. Healthcare providers should be following these updated protocols. These thresholds vary based on the baby’s age in hours and risk factors. Healthcare providers use these guidelines to determine when phototherapy is indicated. It is important to understand that phototherapy is not used as a preventive measure for babies below the treatment threshold, nor is it appropriate for conjugated hyperbilirubinemia, a different type of jaundice that requires investigation of liver or bile duct problems.

During phototherapy, babies wear only a diaper and protective eye shields. Parents can usually hold and feed their baby during breaks in treatment. The duration of phototherapy depends on how quickly bilirubin levels decrease. Some babies may need treatment for just a day, while others require several days of continuous or intermittent light therapy.

For mild cases of jaundice, especially in breastfed babies, healthcare providers may recommend supplementation with formula or donor breast milk. Increasing fluid intake and caloric intake can help the baby pass more stool, which aids in bilirubin elimination. This approach does not mean parents must stop breastfeeding. Rather, supplementation serves as a temporary measure to support bilirubin reduction while maintaining the benefits of breast milk.

In rare cases where bilirubin levels are extremely high or rising rapidly despite phototherapy, an exchange transfusion may be necessary. This procedure involves gradually removing the baby’s blood and replacing it with donor blood to quickly reduce bilirubin levels. Exchange transfusion is reserved for the most severe cases and is performed in a neonatal intensive care unit under careful monitoring.

Risk Factors Including Ethnicity, Feeding, and Discharge Margins

Understanding risk factors can help parents and healthcare providers identify babies who need closer monitoring. Research shows that certain factors increase the likelihood of developing significant hyperbilirubinemia or requiring rehospitalization for jaundice treatment.

• Ethnicity: Studies have found that babies of East Asian descent have higher rates of hyperbilirubinemia compared to other ethnic groups. Awareness of this risk helps providers tailor follow-up plans appropriately.

• Feeding method: Breastfed babies are more likely to develop jaundice than formula-fed babies, particularly in the first week of life. This occurs because breastfed babies may consume less fluid in the first few days before the mother’s milk supply is fully established, leading to mild dehydration and reduced stool output. Additionally, substances in breast milk can slow bilirubin elimination. With proper support and monitoring, most breastfed babies with jaundice do well.

• Discharge timing and bilirubin margins: Infants discharged with bilirubin levels close to the phototherapy threshold have a significantly higher risk of rehospitalization for jaundice treatment. The 2022 AAP guidelines introduced updated discharge criteria to address this risk. This highlights the importance of careful discharge planning and timely follow-up, particularly for babies in higher-risk categories.

Other risk factors include prematurity, significant scalp bruising or cephalohematoma, blood type incompatibility between mother and baby, family history of jaundice requiring treatment, and excessive weight loss after birth. A baby who has lost more than 10 percent of birth weight may be at higher risk because reduced feeding can lead to inadequate stool output and slower bilirubin elimination.

New York Screening and Follow-Up Protocols

New York hospitals follow guidelines established by the American Academy of Pediatrics and the New York State Department of Health to ensure consistent screening and follow-up for newborn jaundice. These protocols are designed to identify at-risk babies before discharge and ensure appropriate monitoring after families go home.

Before a baby leaves the hospital, healthcare providers should perform a bilirubin screening test, assess risk factors, and provide parents with clear instructions about jaundice monitoring and follow-up appointments. Many New York hospitals provide parents with written information about jaundice warning signs and specific instructions about when to call the pediatrician.

Follow-up timing depends on the baby’s risk level. Babies discharged before 72 hours of age, those with bilirubin levels in the intermediate or high-risk zones, and those with other risk factors should be seen by a healthcare provider within 24 to 48 hours after discharge. Even babies without obvious risk factors should have a follow-up visit within three to five days after birth to assess feeding, weight, and jaundice.

During follow-up visits, healthcare providers examine the baby for signs of jaundice, assess feeding and elimination patterns, and may perform repeat bilirubin testing if indicated. Parents should come prepared to discuss how often the baby is feeding, whether the baby is having adequate wet and dirty diapers, and any concerns about the baby’s color or behavior.

New York families should feel empowered to ask questions and advocate for their baby’s care. If a parent notices increasing yellowing, poor feeding, or excessive sleepiness, they should contact their pediatrician immediately rather than waiting for a scheduled appointment. Healthcare providers should respond promptly to these concerns and arrange for bilirubin testing when appropriate.

When to Seek Medical Attention Immediately

While most jaundice is benign, certain situations require immediate medical evaluation. Parents should call their baby’s healthcare provider or seek emergency care if:

• Jaundice appears within the first 24 hours of life.

• The yellowing is spreading rapidly or becoming more intense.

• The baby is extremely sleepy and difficult to wake, refuses to feed, or feeds poorly.

• The baby appears floppy or stiff, arches the head and body backward, or makes high-pitched crying sounds.

• Yellowing extends to the palms of the hands or soles of the feet.

• The baby has a fever or is not having adequate wet and dirty diapers (signs of dehydration).

If a baby has been diagnosed with jaundice and is receiving home phototherapy or other treatment, parents should follow all monitoring instructions carefully and report any concerns immediately. Healthcare providers should give clear guidance about which symptoms warrant an immediate call and which can wait until the next scheduled visit.

When seeking medical attention, parents should be prepared to provide information about when the jaundice was first noticed, how it has changed, the baby’s feeding patterns, and the number of wet and dirty diapers in the past 24 hours. This information helps healthcare providers assess the severity of the situation and determine the appropriate next steps.

Understanding Negligence When Failure to Treat Jaundice Becomes a Legal Issue

Most cases of newborn jaundice are managed appropriately by healthcare providers who follow established screening and treatment protocols. However, when medical professionals fail to screen for jaundice, misinterpret test results, delay necessary treatment, or fail to provide adequate follow-up instructions, the consequences can be severe. In some situations, these failures may constitute medical negligence.

Medical negligence related to jaundice typically involves a failure to meet the standard of care. This can include failing to perform required bilirubin screening before discharge, not recognizing risk factors that require closer monitoring, dismissing parental concerns about a baby’s color or behavior, delaying phototherapy when bilirubin levels meet treatment thresholds, or discharging a baby without appropriate follow-up plans when bilirubin levels are near the phototherapy threshold.

The consequences of untreated severe hyperbilirubinemia can be devastating. Kernicterus, though rare when proper protocols are followed, can cause permanent neurological damage. Children who develop kernicterus may face lifelong challenges including cerebral palsy, hearing loss, vision problems, dental enamel defects, and developmental delays. These outcomes are particularly tragic because kernicterus is largely preventable with timely screening and treatment.

Determining whether negligence occurred requires a careful review of medical records, hospital protocols, and the timing of screening and treatment decisions. Medical experts can evaluate whether healthcare providers followed accepted guidelines and whether different actions could have prevented injury. Factors that may be examined include whether bilirubin screening was performed at appropriate intervals, whether test results were communicated and acted upon promptly, whether treatment was initiated when indicated by established thresholds, and whether discharge planning included appropriate risk assessment and follow-up instructions.

Families who believe their child suffered harm due to inadequate jaundice screening or treatment should consider consulting with a New York Birth Injury Lawyer who can review the medical records and help determine whether the care provided met accepted standards. Legal consultation does not guarantee that negligence occurred, but it can help families understand their options and rights.

Frequently Asked Questions

Is Jaundice in Newborns Always Dangerous?

No, jaundice in newborns is not always dangerous. More than half of all term infants develop some degree of jaundice, and most cases are benign physiologic jaundice that resolves without treatment. The condition becomes concerning when bilirubin levels rise significantly or when jaundice appears very early, before 24 hours of age. With proper screening and treatment when indicated, serious complications are rare.

How Do Doctors Test for Jaundice in Newborns?

Doctors use two main methods to test for jaundice. The transcutaneous bilirubin test is a non-invasive screening tool that estimates bilirubin levels by placing a device on the baby’s skin. If this screening indicates elevated levels or if the baby shows visible signs of jaundice, doctors order a total serum bilirubin test, which requires a small blood sample and provides the most accurate measurement. The blood test is the gold standard for diagnosing hyperbilirubinemia and determining treatment needs.

What Is the Standard Treatment for Neonatal Jaundice?

The standard treatment for neonatal jaundice is phototherapy, which uses special blue lights to help break down bilirubin in the skin. Treatment is started when bilirubin levels reach specific thresholds based on the baby’s age and risk factors. For mild cases, especially in breastfed babies, increasing feeding frequency and supplementing with formula or donor milk may help. In rare severe cases, exchange transfusion may be necessary to rapidly reduce bilirubin levels.

Can Breastfeeding Cause or Worsen Jaundice?

Breastfeeding does not cause jaundice, but breastfed babies are more likely to develop jaundice than formula-fed babies. This happens because breastfed babies may consume less fluid in the first few days before milk supply is established, and substances in breast milk can slow bilirubin elimination. However, this does not mean mothers should stop breastfeeding. With adequate feeding frequency, proper latch support, and monitoring, most breastfed babies with jaundice do well. Temporary supplementation may be recommended in some cases to support bilirubin reduction while maintaining breastfeeding.

When Should I Call My Doctor if My Baby Has Jaundice?

You should call your doctor immediately if jaundice appears within the first 24 hours of life, if yellowing is spreading rapidly or becoming more intense, if your baby is extremely sleepy and difficult to wake, refuses to feed or feeds poorly, shows stiff or floppy movements, has a high-pitched cry, develops a fever, or is not producing adequate wet and dirty diapers. These signs may indicate worsening jaundice, dehydration, or that bilirubin is affecting the nervous system and require prompt evaluation.

What to Do if You Have Concerns About Your Baby’s Jaundice Care

Most cases of newborn jaundice are managed appropriately and resolve without lasting harm. But when screening is delayed, risk factors are ignored, or treatment is not started when bilirubin levels reach established thresholds, the consequences can be permanent and preventable. If your baby was diagnosed with kernicterus, developed hearing loss or cerebral palsy after a jaundice diagnosis, or if you believe bilirubin screening or follow-up was inadequate during your baby’s care in New York, requesting complete copies of medical records is the right first step. A New York birth injury attorney can review those records, consult with medical experts, and help you understand whether the care your baby received met the accepted standard. Under New York CPLR Section 208, families generally have until the child’s tenth birthday to file a birth injury claim — but consulting with an attorney early is always advisable to preserve evidence and meet all applicable deadlines.